4th Pediatric Infectious Diseases Conference
 
 
Home  Back   ISSN 0973 - 0958
 
User name :
Password :
Chemotherapy- General Guidelines
Chemotherapy- General Guidelines
Chemotherapy- General Guidelines
Chemotherapy- General Guidelines
Chemotherapy- General Guidelines
Follow Us : Follow On Facebook Follow On Twitter Follow On Youtube
Pedi Poll
Today's Poll
Should teicoplannin, colistin be used in case of neonatal sepsis where culture does not reveal any organism_?
No, it should be used only after drug sensitivity report
Yes, under guidance of an infectious disease expert
CHEMOTHERAPY- GENERAL GUIDELINES
Chemotherapy- General Guidelines
Dr Ira Shah
M.D, DCH (Gold Medalist), FCPS, DNB
Edited by Dr. Bharat R Agarwal
Consultant Pediatric Hematologist and Oncologist.


Q. Is it true that different chemotherapeutic agents act at different cell cycles?

A. Yes that is true. The cell cycle is divided into the following stages:
  • G0 phase-resting cells
  • G1 phase-proteins and RNA are synthesized
  • S phase-cellular contents of DNA doubles
  • G2 phase-DNA synthesis ceases. Microtubules are formed for mitosis.
  • M phase- Mitosis

    + Cells in the G0 phase are usually refractory to chemotherapy.
    + G1 phase specific drug is L-asparaginase
    + S phase specific drugs are procarbazine, cytarabine, Hydroxyurea, 6-Mercaptopurine, Methotrexate,6-Thioguanine etc.
    + G2 phase specific drugs are Bleomycin, Etoposide.
    + M phase specific drugs are Vincristine and Vinblastine.

Tumors with a large proportion of cells in G0 tend to be relatively chemoresistant. An initial reduction in tumor cell population (e.g. by surgery or radiotherapy) may bring resting cells into cycle (recruitment) thus increasing the susceptibility of cells to subsequent chemotherapy.

Q. How are these agents given?

A. Some drugs like Vincristine, Doxorubicin should be given only intravenously and some drugs like Mercaptopurine, Prednisone are given orally. Preservative-free Methotrexate can be given intrathecally to destroy the cancer cells in the CNS in diseases like Acute leukemias and lymphomas.

All pediatric oncology centers have treatment protocols for cancers. Some commonly used protocols are as follows:
COPP Protocol - Cyclophosphamide, Oncovin(Vincristine), Prednisolone and Procarbazine.
ABVD Protocol- Adriamycin, Bleomycin, Vinblastine and Dacarbazine.
COMP Protocol - Cyclophosphamide, Oncovin, Methotrexate and Prednisolone.
CHOP Protocol - Cyclophosphamide, Hydroxydaunorubicin (Doxorubicin), Oncovin and Prednisolone.

Most of the anticancer drugs are metabolized in the liver and excreted by the kidneys. Hence, before starting chemotherapy, a base line investigation to rule out existing liver and kidney dysfunction should be done.

Q. What are the side effects of these agents?

A. Since they act on rapidly dividing cells, their major toxic effects are seen on the bone marrow, GI tract, and skin and hair. Most of these agents cause nausea, vomiting, mucositis, bone marrow suppression, alopecia and diarrhea. Other side effects are more specific to particular agents e.g.
  • Prednisolone - Bilateral necrosis of head of femur, cushingoid appearance
  • Cyclophosphamide - Sterility, Hemorrhagic cystitis
  • Ifosfamide - Hemorrhagic cystitis
  • Daunorubicin - Cardiomyopathy
  • Doxorubicin - Cardiomyopathy
  • Bleomycin - Pulmonary fibrosis
  • L- asparaginase - Pancreatitis, Thromboembolic phenomenon
  • Vincristine - Peripheral neuropathy

 
 
Educational Section
 
Disclaimer:
The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
 
copyright ©2011 website design & development by Levioza
Follow Us
Follow us on :
Folllow Us